vs

Side-by-side financial comparison of DBV Technologies S.A. (DBVT) and Medalist Diversified REIT, Inc. (MDRR). Click either name above to swap in a different company.

Medalist Diversified REIT, Inc. is the larger business by last-quarter revenue ($2.8M vs $2.8M, roughly 1.0× DBV Technologies S.A.). Medalist Diversified REIT, Inc. runs the higher net margin — -18.8% vs -1195.5%, a 1176.8% gap on every dollar of revenue. On growth, DBV Technologies S.A. posted the faster year-over-year revenue change (158.8% vs 11.8%). Medalist Diversified REIT, Inc. produced more free cash flow last quarter ($77.0K vs $-32.6M). Over the past eight quarters, DBV Technologies S.A.'s revenue compounded faster (12.4% CAGR vs 4.8%).

DBV Technologies SA is a publicly owned French biopharmaceutical firm headquartered in Bagneux, France. DBV Technologies is known for developing "Viaskin" technology for administering allergens or antigens to intact skin while avoiding any transfer to the blood. Viaskin Peanut clinical development has received Fast Track designation from the US Food and Drug Administration.

Medalist Diversified REIT, Inc. is a publicly traded real estate investment trust focused on owning, operating, and acquiring income-generating multi-family residential properties. Its portfolio is concentrated in high-growth US Southeast and Mid-Atlantic markets, targeting stable long-term returns for shareholders via rental income and property appreciation.

DBVT vs MDRR — Head-to-Head

Bigger by revenue
MDRR
MDRR
1.0× larger
MDRR
$2.8M
$2.8M
DBVT
Growing faster (revenue YoY)
DBVT
DBVT
+147.0% gap
DBVT
158.8%
11.8%
MDRR
Higher net margin
MDRR
MDRR
1176.8% more per $
MDRR
-18.8%
-1195.5%
DBVT
More free cash flow
MDRR
MDRR
$32.6M more FCF
MDRR
$77.0K
$-32.6M
DBVT
Faster 2-yr revenue CAGR
DBVT
DBVT
Annualised
DBVT
12.4%
4.8%
MDRR

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
DBVT
DBVT
MDRR
MDRR
Revenue
$2.8M
$2.8M
Net Profit
$-33.2M
$-529.6K
Gross Margin
Operating Margin
-1235.7%
14.8%
Net Margin
-1195.5%
-18.8%
Revenue YoY
158.8%
11.8%
Net Profit YoY
-8.9%
-88.4%
EPS (diluted)
$-0.24
$-0.49

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DBVT
DBVT
MDRR
MDRR
Q4 25
$2.8M
Q3 25
$2.8M
$2.8M
Q2 25
$1.5M
$2.5M
Q1 25
$2.3M
Q4 24
$2.5M
Q3 24
$2.3M
Q2 24
$1.2M
$2.3M
Q1 24
$1.4M
$2.6M
Net Profit
DBVT
DBVT
MDRR
MDRR
Q4 25
$-529.6K
Q3 25
$-33.2M
$-395.9K
Q2 25
$-41.9M
$-456.4K
Q1 25
$-1.0M
Q4 24
$-281.2K
Q3 24
$-527.0K
Q2 24
$-33.1M
$-521.7K
Q1 24
$-27.3M
$1.4M
Operating Margin
DBVT
DBVT
MDRR
MDRR
Q4 25
14.8%
Q3 25
-1235.7%
15.8%
Q2 25
-2806.2%
9.8%
Q1 25
-23.8%
Q4 24
17.7%
Q3 24
13.0%
Q2 24
-2914.9%
9.4%
Q1 24
-2029.7%
Net Margin
DBVT
DBVT
MDRR
MDRR
Q4 25
-18.8%
Q3 25
-1195.5%
-14.2%
Q2 25
-2858.4%
-18.5%
Q1 25
-43.4%
Q4 24
-11.1%
Q3 24
-22.6%
Q2 24
-2852.4%
-22.7%
Q1 24
-1943.5%
52.8%
EPS (diluted)
DBVT
DBVT
MDRR
MDRR
Q4 25
$-0.49
Q3 25
$-0.24
$-0.33
Q2 25
$-0.31
$-0.34
Q1 25
$-0.74
Q4 24
$-0.24
Q3 24
$-0.47
Q2 24
$-0.34
$-0.47
Q1 24
$-0.28
$1.21

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DBVT
DBVT
MDRR
MDRR
Cash + ST InvestmentsLiquidity on hand
$69.8M
$2.6M
Total DebtLower is stronger
$51.4M
Stockholders' EquityBook value
$52.9M
$9.4M
Total Assets
$110.5M
$77.7M
Debt / EquityLower = less leverage
5.45×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DBVT
DBVT
MDRR
MDRR
Q4 25
$2.6M
Q3 25
$69.8M
$1.9M
Q2 25
$103.2M
$2.0M
Q1 25
$2.7M
Q4 24
$4.8M
Q3 24
$3.1M
Q2 24
$66.2M
$3.8M
Q1 24
$101.5M
$3.6M
Total Debt
DBVT
DBVT
MDRR
MDRR
Q4 25
$51.4M
Q3 25
$63.6M
Q2 25
$49.6M
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Stockholders' Equity
DBVT
DBVT
MDRR
MDRR
Q4 25
$9.4M
Q3 25
$52.9M
$10.4M
Q2 25
$86.2M
$13.4M
Q1 25
$14.0M
Q4 24
$15.0M
Q3 24
$12.6M
Q2 24
$79.1M
$13.2M
Q1 24
$111.7M
$13.7M
Total Assets
DBVT
DBVT
MDRR
MDRR
Q4 25
$77.7M
Q3 25
$110.5M
$92.1M
Q2 25
$143.4M
$77.7M
Q1 25
$78.2M
Q4 24
$75.1M
Q3 24
$74.6M
Q2 24
$114.2M
$75.2M
Q1 24
$145.9M
$76.0M
Debt / Equity
DBVT
DBVT
MDRR
MDRR
Q4 25
5.45×
Q3 25
6.13×
Q2 25
3.70×
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DBVT
DBVT
MDRR
MDRR
Operating Cash FlowLast quarter
$-32.4M
$1.5M
Free Cash FlowOCF − Capex
$-32.6M
$77.0K
FCF MarginFCF / Revenue
-1173.5%
2.7%
Capex IntensityCapex / Revenue
4.2%
51.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-138.3M
$1.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DBVT
DBVT
MDRR
MDRR
Q4 25
$1.5M
Q3 25
$-32.4M
$1.6M
Q2 25
$-33.9M
$244.1K
Q1 25
$460.0K
Q4 24
$1.8M
Q3 24
$139.9K
Q2 24
$-35.1M
$778.6K
Q1 24
$-34.7M
$492.4K
Free Cash Flow
DBVT
DBVT
MDRR
MDRR
Q4 25
$77.0K
Q3 25
$-32.6M
$1000.0K
Q2 25
$-33.9M
$-181.5K
Q1 25
$322.4K
Q4 24
$893.7K
Q3 24
$-164.7K
Q2 24
$-35.8M
$645.6K
Q1 24
$-36.0M
$265.8K
FCF Margin
DBVT
DBVT
MDRR
MDRR
Q4 25
2.7%
Q3 25
-1173.5%
35.9%
Q2 25
-2316.5%
-7.4%
Q1 25
13.9%
Q4 24
35.4%
Q3 24
-7.0%
Q2 24
-3084.0%
28.1%
Q1 24
-2560.6%
10.3%
Capex Intensity
DBVT
DBVT
MDRR
MDRR
Q4 25
51.5%
Q3 25
4.2%
20.4%
Q2 25
2.2%
17.3%
Q1 25
5.9%
Q4 24
35.7%
Q3 24
13.0%
Q2 24
63.0%
5.8%
Q1 24
94.9%
8.8%
Cash Conversion
DBVT
DBVT
MDRR
MDRR
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
0.36×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

DBVT
DBVT

Segment breakdown not available.

MDRR
MDRR

Retail Center Properties$1.6M58%
Other$1.2M42%

Related Comparisons